Inamed's new President and CEO Babbitt brings experience leading companies through acquisition.
This article was originally published in The Gray Sheet
Executive SummaryINAMED's NEW PRESIDENT AND CEO RICHARD BABBITT brings experience in leading companies through the process of being acquired. Announcing Babbitt's appointment Jan. 23, McGhan parent Inamed highlights the fact that he led four separate companies (American Safety Equipment, B.I. Industries, Welsh Manufacturing, and Medical Supply Co.) during the time that they were acquired. Babbitt currently serves as president and CEO of privately held, Los Angeles-based DNA Technologies, and also has served as president and general manager of Ben Hogan Group.
You may also be interested in...
US FDA usually recommends using overall survival for pancreatic cancer drugs, but AstraZeneca choose progression-free survival; now ODAC will weigh in on whether the PARP inhibitor olaparib demonstrated a clinically meaningful impact. The firm cites enrollment and design challenges in the gBRCAm population as reasons for using PFS.
Attorneys say Sarepta did not have an obligation to report its appeal, particularly since winning a formal dispute filing with the US FDA is a long shot.